ライフサイエンスコーパス: aspiration pneumonia

1 s measured as incidence of regurgitation and aspiration (pneumonia).

2 epsis, pancreatitis), or direct lung injury (aspiration, pneumonia).

3 th was reported that occurred after onset of aspiration pneumonia.

4 with microbiologically documented bacterial aspiration pneumonia.

5 al status, and one moderate adverse event of aspiration pneumonia.

6 temic diseases including atherosclerosis and aspiration pneumonia.

7 mplementing strategies to reduce the rate of aspiration pneumonia.

8 utcome variable was a discharge diagnosis of aspiration pneumonia.

9 of bacterial cultures in cases of suspected aspiration pneumonia.

10 d as the predominant predisposing factor for aspiration pneumonia.

11 eria can be aspirated into the lung to cause aspiration pneumonia.

12 clinical problems: neurogenic dysphagia and aspiration pneumonia.

13 at significantly greater risk for developing aspiration pneumonia.

14 Secondary outcomes were splenic injury and aspiration pneumonia.

15 one treatment-related death due to an AE of aspiration pneumonia.

16 afferent nerves may be at increased risk of aspiration pneumonia.

17 intracranial pressure, 1.75 (1.31-2.33); and aspiration pneumonia, 1.79 (1.16-2.77).

18 In the treatment of aspiration pneumonia, 27.6% of physicians preferred path

19 ry to a cavitating pulmonary infection after aspiration pneumonia 6 weeks after resection.

20 and choking difficulties, which can lead to aspiration pneumonia, a leading cause of death in late-s

21 ortion of patients with documented bacterial aspiration pneumonia among comatose ICU patients with sy

22 rdiopulmonary anomalies, cerebral palsy, and aspiration pneumonia and among patients with tracheoesop

23 CsA-MMF group died of nonimmunologic causes (aspiration pneumonia and arrhythmia) between 3 and 6 mon

24 Culture-proven aspiration pneumonia and early-onset ventilator-associat

25 The epidemiology of aspiration pneumonia and its impact on clinical and econ

26 iffer between the 43 patients with bacterial aspiration pneumonia and the 49 patients with non-bacter

27 gically impaired patients, which can lead to aspiration pneumonia and thus prolonged hospitalization

28 at are associated with an increased risk for aspiration pneumonia and to determine the clinical and e

29 edures associated with an increased risk for aspiration pneumonia and to determine the impact on inte

30 operative pulmonary complications, including aspiration, pneumonia and hypoxia, impaired hypoxic vent

31 One serious adverse event (one death due to aspiration pneumonia) and no treatment-related deaths we

32 s and oral hygiene help mitigate the risk of aspiration pneumonia, and nutritional supplementation, i

33 eosinophilic syndrome, parvovirus infection, aspiration pneumonia, and severe depression, respectivel

34 mplications, specifically bowel perforation, aspiration pneumonia, and splenic injury.

35 s of 95 institutionalized elders with severe aspiration pneumonia, and to investigate its relation to

36 rrhage presumed related to hepatic peliosis; aspiration pneumonia; and cardiopulmonary failure).

37 The results show that at the site of aspiration pneumonia, anti-CD11b F(ab')2 did not inhibit

38 patients enrolled, 2 patients (15%) died of aspiration pneumonia before receiving FL.

39 nella species were recovered from abscesses, aspiration pneumonias, burns, bites, and sinuses.

40 ciated with typical bacterial infections and aspiration pneumonia but not Legionella infection among

41 iated with a significantly increased risk of aspiration pneumonia, but not bowel perforation or splen

42 C-Ps also protected in a model of fatal aspiration pneumonia by heavily capsulated serotype 3.

43 aspiration pneumonia defined as pneumonia in patients wh

44 se of GLP-1 RAs and short-term postoperative aspiration pneumonia despite growing concerns about the

45 oratory, or radiologic evidence of bacterial aspiration pneumonia did not require antibiotics.

46 mbrolizumab group (one participant each from aspiration pneumonia, end-stage renal disease, pneumonia

47 neumonia in patients with previous recurrent aspiration pneumonia episodes.

48 l-known respiratory complications, including aspiration pneumonia, fistula and airway compression.

49 oor diagnostic value in separating bacterial aspiration pneumonia from aspiration pneumonitis based o

50 y half the patients with suspected bacterial aspiration pneumonia had this diagnosis confirmed by tel

51 theter in these 92 patients showed bacterial aspiration pneumonia in 43 patients (46.7%).

52 importance of adding anaerobic coverage for aspiration pneumonia in institutionalized elders needs t

53 and contributes to survival of severe murine aspiration pneumonia in neutropenic animals.

54 iration (2 patients, with ensuing death from aspiration pneumonia in one patient).

55 ent significantly decreased the incidence of aspiration pneumonia in patients with previous recurrent

56 ions targeting patient-level factors such as aspiration pneumonia in reducing acute stroke fatality i

57 channel engagement may be a risk factor for aspiration pneumonia in susceptible patients.

58 The primary outcome was aspiration pneumonia in the 30-day postoperative period.

59 One patient developed aspiration pneumonia in the postoperative period.

60 Aspiration pneumonia increased in-hospital mortality (re

61 Gastric aspiration pneumonia involves chemical injury to the alv

62 ssion, the few reported studies suggest that aspiration pneumonia is also associated with these poor

63 Aspiration pneumonia is common among frail elderly perso

64 Aspiration pneumonia is the leading cause of pneumonia i

65 Aspiration pneumonia is thought to be associated with a

66 t patients have dysphagia, which can lead to aspiration pneumonia, malnutrition, and adverse function

67 wing problems (dysphagia); increased risk of aspiration pneumonia, malnutrition, and dehydration; and

68 stroke is associated with increased risk of aspiration pneumonia, malnutrition, mortality, and other

69 ved survival in lethal bacteremic sepsis and aspiration pneumonia models of XDR A. baumannii infectio

70 ed: cellulitis (n = 1), esophagitis (n = 1), aspiration pneumonia (n = 1), and tube migration (n = 9)

71 cidal ideation (n=3), head injury (n=3), and aspiration pneumonia (n=3).

72 Aspiration pneumonia occurs in approximately 1% of surgi

73 no systematic review regarding the impact of aspiration pneumonia on the outcomes in patients with CA

74 injury that may progress to life-threatening aspiration pneumonia or acute respiratory distress syndr

75 ts with symptoms suggesting either bacterial aspiration pneumonia or non-bacterial aspiration pneumon

76 AA was associated with an increased risk of aspiration pneumonia (OR, 1.63; 95% CI, 1.11-2.37).

77 three manifested other pathologic findings (aspiration, pneumonia, or thromboemboli).

78 inical intervention can minimize the risk of aspiration pneumonia (PNA), it is generally not well rec

79 patients with advanced dementia can prevent aspiration pneumonia, prolong survival, reduce the risk

80 Microbiological assessment of aspiration pneumonia revealed the absence of any predomi

81 In those with suspected bacterial aspiration pneumonia, stopping empirical antibiotic ther

82 Discoordination leads to aspiration pneumonia, the leading cause of death in neur

83 of 240 patients in group A), diarrhoea, and aspiration pneumonia (two each [1%] of 227 patients in g

84 Given that the rate of aspiration pneumonia varies among hospitals, we can impr

85 The overall prevalence of aspiration pneumonia was 0.8%.

86 In conclusion, aspiration pneumonia was associated with both higher in-

87 In contrast, aspiration pneumonia was associated with decreased ICU m

88 ath in the pridopidine 112.5 mg group due to aspiration pneumonia was considered to be possibly relat

89 dergoing procedures other than tracheostomy, aspiration pneumonia was independently associated with a

90 plasms, fluid and electrolyte disorders, and aspiration pneumonia were the most common primary diagno

91 cation, such as electrolyte disturbances and aspiration pneumonia, were rare in our pediatric patient